Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Five-day intravenous insulin plus enteral feeding feasibility study in hyperglycemic ischemic stroke
NL-OMON31195Phase 4Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human insulin in ischemic stroke and hyperglycemia, sponsored by Amsterdam University Medical Center. Primary endpoints: Glucose profile above target and Glucose profile below lower threshold. Planned start Sep 2007; status: withdrawn.
02
Drugs
human insulin
03
Conditions
ischemic strokehyperglycemia
Beyond the preview
Go deeper on NL-OMON31195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31195.